课题基金 / 基金详情

项目摘要

项目成果

VINCENT CHARLES HASCALL的其他基金

相似基金

相关文献

中文摘要
翻译
来自六个先前的NHLBI卓越计划中的三个的计划主任和教师, 糖科学(PEG)中心与克利夫兰诊所的顶级医生科学家联手 在约翰霍普金斯大学,我们创建了一个独特的职业发展计划, 生物医学研究领域的领导者,涉及聚糖和人类疾病。学者将由一个 广告全国搜索或选择个人谁已经在全国范围内招募的高度 竞争性搜索到心脏病学,肺病学或生物医学工程的当地奖学金计划。 在方案第一周期将选出五名学者。将选出另外五名学者 在该计划的第二个周期。每个学者将有至少两个共同导师,一个是领先的专家, 糖科学和其他高优先级疾病临床/转化研究领域的领先专家 关于NHLBI学者的选择将有利于个人与医学博士。或者医学博士博士℃下的目标 我们的职业发展计划是提供沉浸在最先进的糖科学相关, 人类疾病的学者和他们的临床共同导师。职业发展计划将 包括多方面的沉浸在疾病相关的糖科学。研究经验将是 辅以a)高级专题讲座; B)转化糖科学实例和应用; c) 专题文献综述; d)糖科学系列研讨会;以及e)进行中的研究。将培训以文件形式进行 根据需要在克利夫兰诊所或约翰霍普金斯大学(JHU)进行联播。(f)学者也将参加一个 实践实验室课程,在那里他们将学习进行糖科学研究所需的主要技能。 生物医学糖科学职业发展将进一步得到专业发展的支持 机会,侧重于赠款写作,演讲技巧和网络。出席所有方案 学者的活动将是强制性的。学者的参与和进展将受到集体监督 内部监督委员会由所有首席执行官组成一个正式的电子系统, 评估学者和导师将建立。将对整个方案进行评估 每年由一个由领先的糖科学家组成的外部审查小组进行审查。我们还将监测出版物, 介绍和职业轨迹的现任和前任学者,以评估的整体成功 程序.我们的计划将创造一个医生科学家的干部,他们不仅将成为领导者, 疾病相关的研究,但也将精通所需的糖科学,以了解 疾病的分子基础该计划的真正成功将发生,因为这些学者现在能够通过 当他们独立时,他们对聚糖对自己同伴的重要性的了解 医学科学家
英文摘要
The program directors and faculty from three of the six prior NHLBI Program of Excellence in Glycoscience (PEG) centers have joined forces with top quality physician scientists at the Cleveland Clinic and at Johns Hopkins to create a unique career development program that will train the next generation of leaders in biomedical research involving glycans and human disease. Scholars will be selected by either an advertised national search or by selecting individuals who were already nationally recruited by highly competitive searches to local fellowship programs in cardiology, pulmonology or biomedical engineering. Five scholars will be selected during the first cycle of the Program. Five additional Scholars will be selected in the second cycle of the Program. Each Scholar will have at-least two co-mentors, one a leading expert in glycoscience and the other(s) leading experts in clinical/translational research on a disease of high priority to NHLBI. Selection of Scholars will favor individuals with the M.D. or M.D.-Ph.D. degree. The objectives of our career development program are to provide immersion in state-of-the art glycosciences relevant to human disease for both Scholars and their clinical co-mentors. The career development program will consist of a multi-faceted immersion in disease-related glycosciences. Research experiences will be supplemented by a) advanced topic lectures; b) translational glycoscience examples & applications; c) thematic literature reviews; d) glycoscience seminar series; and e) research in progress. This training will be simulcast at the Cleveland Clinic or Johns Hopkins University (JHU) as needed. f) Scholars will also take a hands-on laboratory course, where they will learn major skills required to do research in glycosciences. Biomedical glycoscience career development will be further supported by professional development opportunities, focused on grant writing, presentation skills, and networking. Attendance at all Program activities by Scholars will be mandatory. Participation and progress of Scholars will be collectively overseen by the internal oversight committee, comprised of all of the Co-P.I.s. A formal electronic system for evaluating both the Scholars and mentors will be established. The overall Program will be evaluated annually by an outside review panel, comprised of leading glycoscientists. We will also monitor publications, presentations and career trajectories of present and former Scholars to evaluate the overall success of the Program. Our Program will create a cadre of physician scientists who not only will become leaders in disease-related research, but also will be well versed in the glycosciences required to understand the molecular basis of disease. True success of the Program will occur as these Scholars are now able to pass on their knowledge of the importance of glycans to their own Fellows when they become independent physician scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immersive Training in Glycosciences
  • 批准号:
    10424530
  • 项目类别:
  • 资助金额:
    $95.49万
  • 财政年份:
    2018
  • 负责人:
    VINCENT CHARLES HASCALL
  • 依托单位:
TSG-6: Novel Regulator of Viral-Induced Hyaluronan Synthesis in Inflamed Airways
  • 批准号:
    9069956
  • 项目类别:
  • 资助金额:
    $31.7万
  • 财政年份:
    2013
  • 负责人:
    VINCENT CHARLES HASCALL
  • 依托单位:
TSG-6: Novel Regulator of Viral-Induced Hyaluronan Synthesis in Inflamed Airways
  • 批准号:
    8849492
  • 项目类别:
  • 资助金额:
    $31.22万
  • 财政年份:
    2013
  • 负责人:
    VINCENT CHARLES HASCALL
  • 依托单位:
Hyaluronan Matrices in Vascular Pathologies
  • 批准号:
    8291915
  • 项目类别:
  • 资助金额:
    $239.82万
  • 财政年份:
    2011
  • 负责人:
    VINCENT CHARLES HASCALL
  • 依托单位:
海外基金